NovaFlowステント胆道システム

NovaFlowステント胆道システム

素材 生体適合材料、 この高度なステントシステムにより、次のことが保証される。 確実な胆道ドレナージ 管開存性を維持し、閉塞を効果的に治療し、胆汁の流れを改善する。

インフォメーション

について NovaFlowステント胆道システム は 高度, 低侵襲 ソリューション restore そして maintain bile duct patency in patients with benign または malignant biliary strictures. Engineered with 堅牢 materials, precision deploymentそして セキュア anchoring mechanisms, NovaFlow helps streamline biliary decompression under endoscopic または fluoroscopic guidance—promoting efficient care and 改良型 patient outcomes.

Key Features & Design

High-Strength Stent Construction
  • Metal or Hybrid Materials (model-dependent): Offers consistent radial force to prop open the constricted duct while accommodating ductal peristalsis.
  • Biocompatible Coatings (if applicable): Minimizes friction or potential ingrowth, supporting better stent patency and easy retrieval when indicated.
  • Low-Profile Catheter: Facilitates navigation through the ampulla and ductal system, 削減 trauma to surrounding tissues.
  • Controlled Deployment: A user-friendly mechanism ensures progressive release of the stent, 限定的 misplacement or sudden expansion.
  • Segmented Design (if applicable): Provides stable tissue contact points, decreasing migration risk in high-flow or dynamic duct segments.
  • Anti-Reflux / Anti-Migration Options (some models): May include flared ends or specialty coatings for long-term stent retention.
  • Fluoroscopic Guidance: Clear marker bands enhance visualization under X-ray, ensuring accurate stent placement across the stricture.
  • リアルタイム・フィードバック: Helps operators confirm final stent positioning and verify full expansion.
  • Metal or Hybrid Materials (model-dependent): Offers consistent radial force to prop open the constricted duct while accommodating ductal peristalsis.
  • Biocompatible Coatings (if applicable): Minimizes friction or potential ingrowth, supporting better stent patency and easy retrieval when indicated.
  • Low-Profile Catheter: Facilitates navigation through the ampulla and ductal system, 削減 trauma to surrounding tissues.
  • Controlled Deployment: A user-friendly mechanism ensures progressive release of the stent, 限定的 misplacement or sudden expansion.
  • Segmented Design (if applicable): Provides stable tissue contact points, decreasing migration risk in high-flow or dynamic duct segments.
  • Anti-Reflux / Anti-Migration Options (some models): May include flared ends or specialty coatings for long-term stent retention.
  • Fluoroscopic Guidance: Clear marker bands enhance visualization under X-ray, ensuring accurate stent placement across the stricture.
  • リアルタイム・フィードバック: Helps operators confirm final stent positioning and verify full expansion.

Clinical Applications & Benefits

Benign & Malignant Biliary Strictures
  • Cholangiocarcinoma, pancreatic または ampullary neoplasms, sclerosing cholangitisあるいは post-surgical strictures: NovaFlow stents facilitate drainage and symptomatic relief of obstructive jaundice.
  • Palliation: Reduces pruritus, cholestasis, and infection risks in advanced disease.
  • Endoscopic Retrograde Cholangiopancreatography (ERCP): Stent introduction and release under endoscopic and/or fluoroscopic guidance, streamlining procedural flow.
  • Percutaneous Access (PTBD): If endoscopic approaches are unfeasible, the stent can be advanced through a percutaneous track (depending on system design).
  • Prompt Symptom Relief: Decompressing the biliary tract alleviates pain, pruritus, and hepatic dysfunction, restoring normal activities faster.
  • Reduced Procedure Frequency: Reliable stent patency and low migration rates diminish the need for multiple re-interventions.
  • Controlled Delivery: Minimizes ductal trauma or false passage creation, crucial in anatomically challenging or fibrotic ducts.
  • Stable Drainage: Intelligent design avoids kinking or stent collapse, preserving ongoing patency.
  • Cholangiocarcinoma, pancreatic または ampullary neoplasms, sclerosing cholangitisあるいは post-surgical strictures: NovaFlow stents facilitate drainage and symptomatic relief of obstructive jaundice.
  • Palliation: Reduces pruritus, cholestasis, and infection risks in advanced disease.
  • Endoscopic Retrograde Cholangiopancreatography (ERCP): Stent introduction and release under endoscopic and/or fluoroscopic guidance, streamlining procedural flow.
  • Percutaneous Access (PTBD): If endoscopic approaches are unfeasible, the stent can be advanced through a percutaneous track (depending on system design).
  • Prompt Symptom Relief: Decompressing the biliary tract alleviates pain, pruritus, and hepatic dysfunction, restoring normal activities faster.
  • Reduced Procedure Frequency: Reliable stent patency and low migration rates diminish the need for multiple re-interventions.
  • Controlled Delivery: Minimizes ductal trauma or false passage creation, crucial in anatomically challenging or fibrotic ducts.
  • Stable Drainage: Intelligent design avoids kinking or stent collapse, preserving ongoing patency.

関連商品